Runnebaum, I B <br/><br/>
Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives.  [electronic resource] 

 -  Pharmacogenetics  Oct 2001 
 - 635-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0960-314X 
<br/><br/><label>Standard No.: </label>10.1097/00008571-200110000-00010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Alleles<br/>Breast Neoplasms--genetics<br/>Contraceptives, Oral--therapeutic use<br/>Female<br/>Genes, BRCA1<br/>Genes, BRCA2<br/>Genetic Carrier Screening<br/>Genetic Predisposition to Disease--genetics<br/>Germ-Line Mutation--genetics<br/>Humans<br/>Middle Aged<br/>Ovarian Neoplasms--genetics<br/>Receptors, Progesterone--genetics<br/>Risk Factors